FBIO übertreffen die 23 der letzten 39Schätzungen.
59%
Nächster Bericht
Datum des nächsten Berichts
24. März 2026
Estimate forQ4 25(Revenue/ EPS)
$23.61M
/
-$0.35
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+33.90%
/
-418.18%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+56.14%
/
-53.33%
Fortress Biotech, Inc. earnings per share and revenue
On 14. Nov. 2025, FBIO reported earnings of 0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 125.68% surprise. Revenue reached 17.63 million, compared to an expected 21.44 million, with a -17.76% difference. The market reacted with a +5.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.35 USD, with revenue projected to reach 23.61 million USD, implying an decrease of -418.18% EPS, and increase of 33.90% in Revenue from the last quarter.
FAQ
What were Fortress Biotech, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fortress Biotech, Inc. reported EPS of $0.11, beating estimates by 125.68%, and revenue of $17.63M, -17.76% below expectations.
How did the market react to Fortress Biotech, Inc.'s Q3 2025 earnings?
The stock price moved up 5.22%, changed from $2.49 before the earnings release to $2.62 the day after.
When is Fortress Biotech, Inc. expected to report next?
The next earning report is scheduled for 24. März 2026.
What are the forecasts for Fortress Biotech, Inc.'s next earnings report?
Based on 4
analysts, Fortress Biotech, Inc. is expected to report EPS of -$0.35 and revenue of $23.61M for Q4 2025.